Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Enzon Pharmaceuticals Inc. (ENZN) had Operating Cash Flow per Share of $-0.04 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-5.53M |
|
-- |
|
-- |
|
$5.31M |
|
$-5.31M |
|
$1.92M |
|
$-3.39M |
|
$-3.39M |
|
$-3.41M |
|
$-3.41M |
|
$-3.41M |
|
$-3.41M |
|
$-5.31M |
|
$-5.31M |
|
74.22M |
|
74.22M |
|
$-0.07 |
|
$-0.07 |
|
| Balance Sheet Financials | |
$42.81M |
|
-- |
|
-- |
|
$42.81M |
|
$0.73M |
|
-- |
|
-- |
|
$0.73M |
|
$-2.52M |
|
$42.08M |
|
$42.08M |
|
74.22M |
|
| Cash Flow Statement Financials | |
$-3.01M |
|
-- |
|
$-1.27M |
|
$46.86M |
|
$42.57M |
|
$-4.29M |
|
-- |
|
-- |
|
$-1.27M |
|
| Fundamental Metrics & Ratios | |
58.57 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.01M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
135.01% |
|
-8.10% |
|
-7.96% |
|
-8.10% |
|
$0.57 |
|
$-0.04 |
|
|
Operating Cash Flow per Share |
$-0.04 |